Central Innovation, now operating as a full-service software provider, has unveiled its Data Solutions Business Unit and ...
Q3 2025 Earnings Call October 23, 2025 4:00 AM EDTCompany ParticipantsPascal Daloz - CEO & DirectorRouven Bergmann ...
WASHINGTON (AP) — The FBI in 2023 analyzed phone records of more than a half dozen Republican lawmakers as part of an investigation into efforts by President Donald Trump to overturn the results of ...
Israeli companies will not take part in the Dubai Airshow 2025, the organiser confirmed on Tuesday. While speaking during a press conference for Dubai Airshow 2025, Timothy Hawes, managing director of ...
Marks & Spencer is closing 11 cafes in its smaller food shops as part of a continued shake-up of its store estate. The high street giant said on Monday that shutting the cafes is part of efforts to ...
President Donald Trump is considering not giving back pay to all federal employees once the government shutdown ends, suggesting it could depend on the worker in the GOP’s latest attempt to force ...
The Buffalo Bills look to nab their fifth consecutive win when they take on the New England Patriots on Sunday Night Football. If Bills quarterback Josh Allen and Co. come out victorious, they will be ...
GameSpot may get a commission from retail offers. Unlike the previous two entries in the Final Fantasy 7 Remake trilogy that launched exclusively for PlayStation consoles--with Switch 2 and Xbox ...
In a major corporate development, Gillette Pakistan Limited announced that its parent company, Procter & Gamble (P&G), will discontinue its business operations in Pakistan as part of a global ...
Microsoft has added more than 90 new titles to Xbox Game Pass as part of a controversial update that’s made the service a lot more expensive. Essential is now the cheapest tier of Xbox Game Pass and ...
Netflix's gripping new psychological thriller, Ángela, is storming the streaming platform's top ten TV chart. The six-part Spanish-language series, which has been hailed by viewers as "absorbing" and ...
Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results